Synthesis of glucose-chlorambucil derivatives and their recognition by the human GLUT1 glucose transporter.

[1]  V. Hruby,et al.  Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Shigemoto,et al.  Distribution of the glucose transporters in human brain tumors. , 1992, Cancer research.

[3]  N. Greig,et al.  Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier. , 1992, Cancer research.

[4]  W. Pardridge.  Peptide drug delivery to the brain , 1991 .

[5]  D. Begley,et al.  Permeability of the Blood‐Brain Barrier to the Immunosuppressive Cyclic Peptide Cyclosporin A , 1990, Journal of neurochemistry.

[6]  I. Tamai,et al.  Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells. , 1990, The Journal of biological chemistry.

[7]  Kazutomo Inoue,et al.  Over-expression of facilitative glucose transporter genes in human cancer. , 1990, Biochemical and biophysical research communications.

[8]  A. Carruthers,et al.  Analysis of protein-mediated 3-O-methylglucose transport in rat erythrocytes: rejection of the alternating conformation carrier model for sugar transport. , 1989, Biochemistry.

[9]  M Danhof,et al.  Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. , 1988, The Journal of pharmacology and experimental therapeutics.

[10]  T. J. Wheeler,et al.  Infinite-cis kinetics support the carrier model for erythrocyte glucose transport. , 1988, Biochemistry.

[11]  S. Jarvis.  Inhibition by nucleosides of glucose-transport activity in human erythrocytes. , 1988, The Biochemical journal.

[12]  A. Carruthers,et al.  Equilibrium ligand binding to the human erythrocyte sugar transporter. Evidence for two sugar-binding sites per carrier. , 1987, The Journal of biological chemistry.

[13]  N. Greig,et al.  Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. , 1987, Cancer research.

[14]  A. Walmsley,et al.  The kinetics of glucose transport in human red blood cells. , 1986, Biochimica et biophysica acta.

[15]  H Kutchai,et al.  Asymmetric transport of a fluorescent glucose analogue by human erythrocytes. , 1985, Biochimica et biophysica acta.

[16]  Joseph C. LaManna,et al.  Regional comparisons of brain glucose influx , 1985, Brain Research.

[17]  A. Klip,et al.  Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Pardridge.  Brain metabolism: a perspective from the blood-brain barrier. , 1983, Physiological reviews.

[19]  N. Bodor,et al.  Site-specific, sustained release of drugs to the brain. , 1981, Science.

[20]  V A Levin,et al.  Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. , 1980, Journal of medicinal chemistry.

[21]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[22]  G. Holman,et al.  Evidence for two asymmetric conformational states in the human erythrocyte sugar-transport system. , 1975, The Biochemical journal.

[23]  M Hatanaka,et al.  Transport of sugars in tumor cell membranes. , 1974, Biochimica et biophysica acta.

[24]  G. Holman,et al.  Structural requirements for binding to the sugar-transport system of the human erythrocyte. , 1973, The Biochemical journal.

[25]  A. Mcinnes,et al.  THE ALCOHOLYSIS OF TRIALKYLALKOXYSILANES. PART II. THE PREPARATION AND CHEMISTRY OF METHYL 2,3,4-TRI-O-TRI-METHYLSILYL-ALPHA-DGLUCOPYRANOSIDE, , 1965 .

[26]  Y. Ahn,et al.  Expression of glucose transporter isoforms (GLUT1, GLUT2) and activities of hexokinase, pyruvate kinase, and malic enzyme in preneoplastic and neoplastic rat renal basophilic cell lesions , 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

[27]  D. Néel,et al.  [Variability of biological glucose transport activity in human erythrocytes]. , 1991, Comptes rendus des seances de la Societe de biologie et de ses filiales.

[28]  M. Melamed,et al.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Pardridge.  Recent advances in blood-brain barrier transport. , 1988, Annual review of pharmacology and toxicology.

[30]  A. Hassner,et al.  Direct room temperature esterification of carboxylic acids , 1978 .

[31]  T. Steck,et al.  Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. , 1974, Methods in enzymology.